UBLITUXIMAB-XIIY for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 661 adverse event reports in the FDA FAERS database where UBLITUXIMAB-XIIY was used for Multiple sclerosis.
Most Reported Side Effects for UBLITUXIMAB-XIIY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 481 | 53.4% | 0 | 18 |
| Fatigue | 48 | 5.3% | 0 | 2 |
| Headache | 34 | 3.8% | 0 | 3 |
| Malaise | 22 | 2.4% | 0 | 0 |
| Inappropriate schedule of product administration | 21 | 2.3% | 0 | 0 |
| Product dose omission issue | 19 | 2.1% | 0 | 1 |
| Asthenia | 18 | 2.0% | 1 | 3 |
| Drug ineffective | 18 | 2.0% | 1 | 0 |
| Nausea | 18 | 2.0% | 1 | 2 |
| Dizziness | 17 | 1.9% | 1 | 1 |
| Covid-19 | 16 | 1.8% | 0 | 1 |
| Off label use | 16 | 1.8% | 0 | 1 |
| Pyrexia | 16 | 1.8% | 0 | 1 |
| Urinary tract infection | 16 | 1.8% | 0 | 3 |
| Back pain | 15 | 1.7% | 0 | 0 |
Other Indications for UBLITUXIMAB-XIIY
Product used for unknown indication (173)
Relapsing multiple sclerosis (19)
Relapsing-remitting multiple sclerosis (18)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)